NEW YORK (GenomeWeb News) – A significant proportion of parents who get genetic testing for mutations in the breast and ovarian cancer-related genes BRCA1 and BRCA2 are sharing those test results with their children, according to a survey-based study of hundreds of parents appearing online today in the journal Cancer.

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit.